Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.

Similarly, adrenal insufficiency was linked to prolonged PFS in both ICI‐naïve and Ate/Bev‐experienced patients; however, OS benefit did not reach statistical significance (Figure S4 ).

also in 111,027 other papers